Ysios Capital | AM Pharma
< href=http://rxbuywithoutprescriptiononline.net/propecia.html>Propecia no prescription < href=http://rxbuywithoutprescriptiononline.org/lasix.html>lasix buy Sertraline online < href=http://rxnoprescriptionbuyonlinerx.net>Accutane without prescription buy trazodone online buy Zyban without prescription < href=http://rxbuyonlinewithoutprescription.net/zetia.html>zetia without prescription < href=http://rxbuywithoutprescriptiononline.net/clomid.html>Clomid Without Prescription < href=http://rxbuywithoutprescriptiononline.org/ventolin.html>buy ventolin < href=http://rxnoprescriptionbuyonline.com/strattera.html>buy Strattera < href=http://rxbuyonlinewithoutprescriptionrx.net/valtrex.html>buy Valtrex online < href=http://rxbuywithoutprescriptiononline.net/zithromax.html>buy Zithromax without prescription
portfolio

AM Pharma

AM-Pharma B.V. is a biopharmaceutical company focused on preclinical and clinical development of alkaline phosphatase (AP) as a treatment for severe inflammatory diseases.
 
 
AM-Pharma
 

Details
“De Rumpst”
Rumpsterweg 6
3981 AK, Bunnik
The Netherlands
T. + 31 (0)30 228 92 22
F. + 31 (0)30 228 92 20
www.am-pharma.com

 
AM Pharma news

09.03.18
AM-Pharma announces Phase II study results of recAP in sepsis-associated Acute Kidney Injury

22.05.17
AM-Pharma completes patient recruitment of recombinant human Alkaline Phosphatase (recAP) Phase II trial in Acute Kidney Injury

10.05.16
AM-Pharma publishes safety and pharmacokinetic data from Phase I recAP trial

Read more
This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies. For more information on cookies check http://www.ysioscapital.com/legal-notice/ I agree